• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单个核苷酸多态性作为修饰因子,与 RET V804M 原癌基因突变的 2 个大型非相关家族中的髓样和同时髓样/乳头甲状腺癌的发展相关。

Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation.

机构信息

Department of Surgery, Jersey Shore University Medical Center, Neptune, NJ 07754, USA.

出版信息

Surgery. 2010 Dec;148(6):1274-80; discussion 1280-1. doi: 10.1016/j.surg.2010.09.004.

DOI:10.1016/j.surg.2010.09.004
PMID:21134561
Abstract

BACKGROUND

Single nucleotide polymorphisms (SNPs) may function as modifiers of the RET proto-oncogene, resulting in the expression of medullary thyroid carcinoma (MTC) and papillary thyroid carcinoma (PTC). We present 2 non-related Italian-American families (Family 1, n = 107; Family 2, n = 31) with the RET V804M mutation. We have correlated the presence of specific SNPs and the rare RET V804M mutation to MTC, C-cell hyperplasia (CCH), and PTC.

METHODS

Sequencing was performed on exons 10, 11, and 13-16 of the RET proto-oncogene. The presence of MTC, CCH, and PTC were correlated to specific SNPs.

RESULTS

In both families, 3 SNPs in exon 11 (G691S), exon 13 (L769L), and exon 15 (S904S) were detected in 100% of patients with overt MTC. The SNP L769L was present in all patients including patients with PTC, MTC, and CCH.

CONCLUSION

SNP analysis revealed a similar pattern between the 2 families. SNPs in exon 11 (G691S) and exon 15 (S904S) appear to influence the development of MTC. A SNP in exon 13 (L769L) may serve as a modifier in the development of simultaneous MTC and PTC, as well as presentation of MTC, in patients with the RET V804M mutation.

摘要

背景

单核苷酸多态性(SNP)可能作为 RET 原癌基因的修饰物,导致髓样甲状腺癌(MTC)和甲状腺乳头状癌(PTC)的表达。我们介绍了两个无血缘关系的意大利裔美国家庭(家族 1,n = 107;家族 2,n = 31),这些家庭都携带有 RET V804M 突变。我们已经将特定 SNP 的存在与罕见的 RET V804M 突变与 MTC、C 细胞增生(CCH)和 PTC 相关联。

方法

对 RET 原癌基因的外显子 10、11 和 13-16 进行测序。将 MTC、CCH 和 PTC 的存在与特定 SNP 相关联。

结果

在这两个家族中,在外显子 11(G691S)、外显子 13(L769L)和外显子 15(S904S)中发现了 3 个 SNP,在有明显 MTC 的患者中,这 3 个 SNP 的出现率为 100%。L769L SNP 存在于所有患者中,包括患有 PTC、MTC 和 CCH 的患者。

结论

SNP 分析揭示了这两个家族之间的相似模式。外显子 11(G691S)和外显子 15(S904S)中的 SNP 似乎影响 MTC 的发展。外显子 13(L769L)中的 SNP 可能作为 RET V804M 突变患者中同时发生 MTC 和 PTC 以及 MTC 表现的修饰物。

相似文献

1
Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation.单个核苷酸多态性作为修饰因子,与 RET V804M 原癌基因突变的 2 个大型非相关家族中的髓样和同时髓样/乳头甲状腺癌的发展相关。
Surgery. 2010 Dec;148(6):1274-80; discussion 1280-1. doi: 10.1016/j.surg.2010.09.004.
2
One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C?107名家庭成员存在转染期间重排的V804M原癌基因突变,表现为同时患有甲状腺髓样癌和乳头状癌、罕见的原发性甲状旁腺功能亢进,且无嗜铬细胞瘤:这是一种新的综合征——MEN 2C吗?
Surgery. 2009 Dec;146(6):998-1005. doi: 10.1016/j.surg.2009.09.021.
3
Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma?RET原癌基因第13外显子和第14内含子的多态性:甲状腺髓样癌的遗传修饰因子?
J Clin Endocrinol Metab. 2005 Nov;90(11):6232-6. doi: 10.1210/jc.2005-1278. Epub 2005 Aug 23.
4
Polymorphisms in the RET proto-oncogene and the phenotypic presentation of familial medullary thyroid carcinoma.RET原癌基因多态性与家族性甲状腺髓样癌的表型表现
Thyroid. 2004 Oct;14(10):848-52. doi: 10.1089/thy.2004.14.848.
5
Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer.G691S、L769L、S836S 和 S904S 这 4 种 RET 变异与散发性甲状腺髓样癌的临床相关性。
Clin Endocrinol (Oxf). 2012 May;76(5):691-7. doi: 10.1111/j.1365-2265.2011.04293.x.
6
The occurrence and the type of germline mutations in the RET gene in patients with medullary thyroid carcinoma and their unaffected kindred's from Central Poland.波兰中部甲状腺髓样癌患者及其未受影响亲属中RET基因种系突变的发生情况及类型
Cancer Invest. 2007 Dec;25(8):742-9. doi: 10.1080/07357900701518735.
7
Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients.RET原癌基因多态性在土耳其散发性甲状腺髓样癌患者中的意义。
J Endocrinol Invest. 2006 Nov;29(10):858-62. doi: 10.1007/BF03349187.
8
A rare RET gene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening.在两个患有家族性甲状腺髓样癌的希腊家族中发现一种罕见的RET基因外显子8突变:对筛查的意义。
Clin Endocrinol (Oxf). 2006 May;64(5):561-6. doi: 10.1111/j.1365-2265.2006.02509.x.
9
Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.2A 型多发性内分泌腺瘤病家系中 RET 密码子 804 突变患者预防性甲状腺切除术的经验。
Clin Endocrinol (Oxf). 2005 Dec;63(6):636-41. doi: 10.1111/j.1365-2265.2005.02394.x.
10
Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.MEN2家族儿童的遗传性髓样癌预防、风险评估及RET基因
J Pediatr Surg. 2007 Feb;42(2):326-32. doi: 10.1016/j.jpedsurg.2006.10.005.

引用本文的文献

1
Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the .甲状腺髓样癌的分子基础与自然史:(几乎)都与……有关 。 (你提供的原文最后不完整,所以译文也只能到这个程度)
Cancers (Basel). 2023 Oct 5;15(19):4865. doi: 10.3390/cancers15194865.
2
The synergy of germline C634Y and V292M RET mutations in a northern Chinese family with multiple endocrine neoplasia type 2A.一个中国北方家族中胚系 C634Y 和 V292M RET 突变的协同作用与 2A 型多发性内分泌肿瘤。
J Cell Mol Med. 2020 Nov;24(22):13163-13170. doi: 10.1111/jcmm.15922. Epub 2020 Sep 29.
3
Epidemiology of Simultaneous Medullary and Papillary Thyroid Carcinomas (MTC/PTC): An Italian Multicenter Study.
髓样癌与甲状腺乳头状癌同时发生(MTC/PTC)的流行病学:一项意大利多中心研究
Cancers (Basel). 2019 Oct 9;11(10):1516. doi: 10.3390/cancers11101516.
4
Familial MTC with exon 8 Gly533Cys mutation: origin and prevalence of second malignancy.伴有第8外显子Gly533Cys突变的家族性甲状腺髓样癌:第二原发恶性肿瘤的起源与患病率
Endocr Connect. 2017 Nov;6(8):676-684. doi: 10.1530/EC-17-0147. Epub 2017 Sep 26.
5
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.RET、BRAF和RAS癌基因的经典点突变在同一腺体中同时发生的甲状腺乳头状癌和甲状腺髓样癌中并不相同。
J Endocrinol Invest. 2017 Jan;40(1):55-62. doi: 10.1007/s40618-016-0526-5. Epub 2016 Aug 17.
6
Papillary thyroid carcinoma and multiple endocrine neoplasia type 2.甲状腺乳头状癌与2型多发性内分泌腺瘤病
J Endocrinol Invest. 2015 Nov;38(11):1233-7. doi: 10.1007/s40618-015-0290-y. Epub 2015 Apr 23.
7
Characterization of V804M-mutated RET proto-oncogene associated with familial medullary thyroid cancer, report of the largest Turkish family.与家族性甲状腺髓样癌相关的V804M突变型RET原癌基因的特征分析:最大的土耳其家族报告
J Endocrinol Invest. 2015 May;38(5):541-6. doi: 10.1007/s40618-014-0224-0. Epub 2014 Dec 12.
8
Synchronous occurrence of medullary and papillary carcinoma of the thyroid in a patient with cutaneous melanoma: determination of BRAFV600E in peripheral blood and tissues. Report of a case and review of the literature.皮肤黑色素瘤患者甲状腺髓样癌与乳头状癌的同步发生:外周血和组织中BRAFV600E的检测。1例病例报告及文献复习
Endocr Pathol. 2014 Sep;25(3):324-31. doi: 10.1007/s12022-014-9303-1.
9
Familial multinodular goiter syndrome with papillary thyroid carcinomas: mutational analysis of the associated genes in 5 cases from 1 Chinese family.家族性多发性甲状腺结节伴甲状腺乳头状癌:1 个中国家族 5 例相关基因突变分析。
BMC Endocr Disord. 2013 Oct 21;13:48. doi: 10.1186/1472-6823-13-48.
10
Metachronous appearance of second malignancies in medullary thyroid carcinoma (MTC) patients: a diagnostic challenge and brief review of the literature.甲状腺髓样癌(MTC)患者第二恶性肿瘤的异时性表现:诊断挑战及文献简述。
Endocrine. 2013 Dec;44(3):610-5. doi: 10.1007/s12020-013-9961-7. Epub 2013 Apr 23.